Publicacións nas que colabora con Roberto Piñeiro Cid (20)

2024

  1. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

    Molecular & cellular proteomics : MCP

2023

  1. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  2. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

    Biomaterials Science

  3. Magnetically propelled chained nanocomposites for biologically relevant media exploration

    Journal of Colloid and Interface Science, Vol. 629, pp. 287-296

2022

  1. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

  2. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients

    Molecular and Cellular Proteomics, Vol. 21, Núm. 12

  3. What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine

    Cancers, Vol. 14, Núm. 9

  4. Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer

    Frontiers in Pharmacology, Vol. 13

2021

  1. Dissecting breast cancer circulating tumor cells competence via modelling metastasis in zebrafish

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

2020

  1. Corrigendum to “Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells” [Materials Today Chemistry 16 (2020) 100265] (Materials Today Chemistry (2020) 16, (S2468519420300252), (10.1016/j.mtchem.2020.100265))

    Materials Today Chemistry

  2. Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells

    Materials Today Chemistry, Vol. 16

2019

  1. The role of clonal communication and heterogeneity in breast cancer

    BMC Cancer, Vol. 19, Núm. 1

2007

  1. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism

    Journal of Endocrinological Investigation, Vol. 30, Núm. 6, pp. 470-476

2006

  1. Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis

    Cardiovascular Research, Vol. 71, Núm. 1, pp. 118-128

  2. Influencia del sexo en la expresión de adiponectina y leptina en el tejido adiposo epicárdico y subcutáneo. Estudio en pacientes sometidos a cirugía cardiaca

    Revista Espanola de Cardiologia, Vol. 59, Núm. 12, pp. 1252-1260

2005

  1. Adiponectin is synthesized and secreted by human and murine cardiomyocytes

    FEBS Letters, Vol. 579, Núm. 23, pp. 5163-5169

  2. Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes

    Endocrine Research, Vol. 31, Núm. 4, pp. 375-386

2004

  1. GH prevents apostosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism

    Journal of Endocrinology, Vol. 180, Núm. 2, pp. 325-335

  2. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes

    Cardiovascular Research, Vol. 62, Núm. 3, pp. 481-488

2003

  1. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of α1-adrenergic blockade

    Circulation, Vol. 107, Núm. 1, pp. 127-131